Fuad El-Hibri Yale Health Care Advisory Board

June 21st, 2009 admin

Mr. Fuad El-Hibri has served as chief executive officer and chairman of the board of directors of Emergent Biosolutions Inc., since June 2004 and as president from March 2006 to April 2007. Mr. El-Hibri served as chief executive officer and chairman of the board of directors of BioPort Corporation from May 1998 until June 2004, when, as a result of corporate reorganization, BioPort became a wholly owned subsidiary of Emergent. Mr. El-Hibri served as chairman of Digicel Holdings, Ltd., a privately held telecommunications firm, from August 2000 to October 2006. Fuad El-Hibri Yale Health Care Advisory Board

Fuad El-Hibri, MBA
Chief Executive Officer and Chairman of the Board of Directors
Emergent Biosolutions, Inc.
Yale School of Management

Mr. El-Hibri has served as chairman of East West Resources Corporation, a venture capital and financial consulting firm, since June 1990. He served as president of East West Resources from September 1990 to January 2004. Mr. El-Hibri is a member of the board of trustees of American University and a member of the board of directors of the International Biomedical Research Alliance, an academic joint venture among the NIH, Oxford University and Cambridge University. He also serves as chairman and treasurer of El-Hibri Charitable Foundation. Mr. El-Hibri received a master’s degree in public and private management from Yale University and a B.A. in economics from Stanford University.
Reblog this post [with Zemanta]

Related posts:

  1. Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax ROCKVILLE, Md., — Emergent BioSolutions Inc. (NYSE:EBS) announced on June...
  2. Emergent BioSolutions Chairman and CEO Fuad El-Hibri Appointed to U.S. Chamber of Commerce Board of Directors ROCKVILLE, Md., Jun 13, 2011 (BUSINESS WIRE) — Emergent BioSolutions...
  3. Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference in London Emergent BioSolutions Inc. (NYSE: EBS) will be webcasting its presentation...
  4. Emergent BioSolutions on Track to Complete Delivery of 14.5M Doses of BioThrax to the US Government Ahead of Schedule ROCKVILLE, Md., May 31, 2011 (BUSINESS WIRE) — Emergent BioSolutions...
  5. Fuad El-Hibri Interviewed by Ricardo Karam Fuad El-Hibri was interviewed a few months ago by...

Related posts brought to you by Yet Another Related Posts Plugin.

Categories: BioThrax, Earnings Report, El-Hibri Foundation, El-Hibri Fuad, El-Hibri Peace Education, El-Hibri Peace Education Prize, Emergent BioSolutions, Entrepreneur of the Year, Ernst & Young, FDA, Food and Drug Administration, Fuad El-Hibri, Fuad Elhibri, Hepatitis B Vaccine, Hepatitis Vaccine, Islam, Shareholders, Uncategorized, W. James Jackson, Washington DC, Washington Gala, Yale Health Care, Yale School of Management, Yale University Tags: , , , , , , ,
Comments are closed.